Upskilling and reskilling: Key to driving innovation in India’s pharma sector
A skilled workforce is critical to addressing the complexities of modern drug development and personalised medicine.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Anil Matai
Bhushan Akshikar appointed OPPI President
Current President Suresh Pattathil, Managing Director and General Manager, AbbVie India passes the baton on to Bhushan Akshikar
DCGI waives off local trials for drugs approved in well-regulated markets
The countries on the list include the US, UK, Japan, Australia, Canada and the EU
Union Budget 2024-25 reflects a forward-looking and inclusive approach
Anil Matai, Director General, OPPI expressed that while positive strides were taken in the Union Budget 2024-25, the pharma sector…
OPPI urges government to boost R&D and innovation in pharma sector ahead of Union Budget
Anil Matai, Director General of OPPI, highlights key recommendations for enhancing pharmaceutical development in India
Navigating the seas of change: Leadership in the age of disruption
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) opines that leadership in this era of…
Anil Matai appointed Director-General of OPPI
Anil Matai, a general management professional, has extensive experience in the life sciences space
Jashvik Capital appoints Anil Matai and Vijender Singh as Operating Partners
Singh was most recently CEO of Metropolis Healthcare and COO of Dr Lal Pathlabs, while Matai was most recently Managing Director…